PhD Doctoral Researcher Positions in Infectious Diseases, Antimicrobial Resistance, and Related Disciplines at the University of Helsinki University of Helsinki in Canada

The University of Helsinki is inviting applications for 30 salaried doctoral researcher positions across several disciplines through the EU-funded RESDOC (Training Doctoral Excellence for Resilient and Just Future) project. These are PhD-level openings at the University of Helsinki Doctoral School, offered as four-year fixed-term, full-time employment contracts.

One highlighted theme is “Infectious diseases and antimicrobial resistance in changing environments”, which is especially relevant for applicants interested in antimicrobial resistance (AMR), infectious diseases, bioactivity screening, drug discovery, pharmaceutical biosciences, and related research. The linked research group, Bioactivity Screening at the Faculty of Pharmacy, focuses on antimicrobial drug discovery, high-throughput screening, bacterial bioreporters, target-based and cell-based screening, host-pathogen interactions, and natural products.

The positions are part of an international, interdisciplinary doctoral training project and are intended for candidates who can be enrolled in a relevant doctoral programme at the University of Helsinki. The post is suitable for students aiming to complete a PhD in a research environment connected to pharmacy, microbiology, medicinal discovery, and translational biomedical research.

Funding: salaried positions; no tuition details are stated in the post. The project is co-funded by the European Union’s Horizon Europe MSCA COFUND scheme and the University of Helsinki.

Deadline: 31 August 2026, 23:59 Helsinki time.

How to apply: Read the official job advertisement, identify the theme and research group that best match your interests, and submit your application through the University of Helsinki jobs portal before the deadline. If you are specifically interested in AMR, review the Bioactivity Screening group page and the RESDOC theme information linked in the post.